Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chronic Kidney Disease CKD

Similar presentations


Presentation on theme: "Chronic Kidney Disease CKD"— Presentation transcript:

1 Chronic Kidney Disease CKD

2 Definition of Chronic Kidney Disease
Kidney Damage for ≥ 3 months as defined by structural or functional abnormalities of the kidney with or without decreased GFR: blood, urine, imaging, or pathological abnormalities.

3 Definition of Chronic Kidney Disease
GFR ≤ 60 ml/min/ 1.73 m² for ≥ 3 months, with or without damage.

4 Stages of Chronic Kidney Disease
Stage 1 CKD GFR is > 90 mL/ min Stage 2 CKD GFR is mL/min Stage 3 CKD GFR is mL/min Stage 4 CKD GFR is mL/min Stage 5 CKD GFR is < 15 mL/min

5 Etiology of Chronic Kidney Disease
Diabetes % HTN % Glomerular disorders % Underlying renal disease all other causes 18% Automimmune disease Polycystic kidney disease Other Infections Obstructive uropathy Interstitial disorders

6 Risk Factors for Chronic Kidney Disease
Diabetes HTN Age Family history of kidney disease or diabetes Male gender

7 Risk Factors for Chronic Kidney Disease cont..
Racial ethnic background African American Native American Asian American Pacific Islander Latin American Tobacco use

8 Risk Factors for Chronic Kidney Disease cont..
Coexisting kidney disease Anemia High protein diet (controversial) Hyperlipidemia

9 Risk Factors for Chronic Kidney Disease cont..
Atherosclerosis Obesity Exposure to nephrotoxic drugs NSAIDS Contrast Dye Hydrocarbons

10 Recommended Screening Tests for Chronic Kidney Disease
Serum Creatinine Blood Pressure Glucose Urinalysis Microalbuminuria/Proteinuria

11 Evaluation of Chronic Kidney Disease
Laboratory testing Serum creatinine should NOT be used alone to assess kidney function Level of GFR is most accurate predictor Utilize prediction equations, such as MDRD and Cockroft-Gault to calculate GFR

12 Urinalysis Abnormalities of urine sediment RBC and RBC casts
WBC and WBC casts Tubular cells Cellular casts Granular casts Fats

13 Microalbuminuria/Proteinuria
Albumin excretion above the normal range (> 30 mg/24 hrs) Increased excretion of albumin is a more sensitive marker for Chronic Kidney Disease secondary to diabetes, glomerular disease and hypertension than proteinuria

14 Protein/Creatinine Ratio
Collection of timed urine sample is inaccurate and inconvenient Spot urine protein to creatinine ratio provides an accurate estimate of urinary protein excretion rate and is unaffected by hydration state Normal < 200 mg/dl

15 Proteinuria Detection allows identification of CKD in asymptomatic individuals Key finding in the differential diagnosis of type of CKD Key prognostic indicator (increasing level) is associated with greater loss of kidney function

16 Proteinuria Beneficial therapy to reduce proteinuria
ACE inhibitors and ARBs lower glomerular capillary pressure and decrease protein filtration, conferring a “reno-protective” effect on the kidney First choice in individuals with diabetes and may be used in non-diabetics with or without proteinuria

17 Radiographic Studios Ultrasound
General appearance, increased echogenicity , size disparities and scarring, doppler interrogation

18 Radiographic Studios cont..
Intravenous pyelography (IVP) Risk from use of iodinated dyes, used infrequently

19 Radiographic Studios cont..
CT Obstruction, tumors, cysts, ureteral calculi CT with contrast may show renal artery stenosis MRI Renal vein thrombosis, mass lesions MR angiography with gadolinium to preserve renal function

20 Nuclear Scan Symmetry of kidney size or function, RAS, acute pyelonephritis, or scarring

21 Renal Biopsy Invasive procedure to determine the nature and extent of kidney disease Provides information on the diagnosis

22 Renal Biopsy cont.. May guide the treatment of kidney disease
Provide prognosis information

23 Management of CKD Stages 1 and 2
B/P control Goal 130/80 or 125/75 with proteinuria Diabetes control A1C hemoglobin goal < 7.0

24 Management of CKD Stages 1 and 2 cont..
Use of ACE I or ARB Reduce proteinuria Avoid nephrotoxins

25 Blood Pressure Control
B/P Goal <130/80 or < 125/75 with proteinuria Therapeutic Lifestyle Changes, such as: Weight loss Smoking cessation Dietary counseling Exercise

26 Blood Pressure Control cont..
Indications for use of ACEI or ARB Diabetic kidney disease Non-diabetic kidney disease with spot urine protein/creatinine ratio > mg/g ACEI & ARB’s can be used as alternatives to each other or in conbination to lower B/P and reduce proteinuria

27 Monitoring Therapy Monitor for: Hypotension Decreased GFR Hyperkalemia
May continue if serum potassium is < 5.5 or decline of GFR < 30% in 4 months

28 Glycemic Control Intensive glycemic control has been shown to slow progression of CKD ADA recommendation Hgb A1C < 7.0% FPG < 120 mg/dl

29 Glycemic Control cont.. Routine annual testing for microalbuminuria and serum creatinine to determine GFR Early intervention with ACE or ARB with microalbuminuria Pt at risk to develop hypoglycemia due to prolonged half life of insulin in circulation

30 Lipid Control CKD is a CHD risk equivalent LDL goal < 100

31 Timely Referral to Nephrology
Referral indications Uncontrolled HTN on numerous agents Proteinuria > 1Gm/24 hr Estimated GFR < 60 ml/min

32 Early Intervention When creatinine level reaches 1.5 to 2.0 mg/dl most patients have lost more than one half of their GFR

33 Stage 3 GFR 59 - 30 ml/min Evaluate and treat complications
Slow Progression

34 Anemia Management Iron replacement if ferritin less than 300 or percent of transferrin saturation less than 20% Oral iron IV iron Administer Erythropoiten

35 Bone Disease and Disorders of Calcium and Phosphorous Metabolism
Osteitis fibrosa cystica: most common in CKD, associated with high PTH levels Adynamic bone disease: associated with low or normal PTH levels

36 Bone Disease High serum phosphorus: Low phosphorus diet
Phosphate binders: Calcium carbonate or Sevalamer

37 Metabolic Acidosis Acid base disorder characterized by a fall in serum bicarbonate concentration

38 Metabolic Acidosis Failure to treat may: Decrease bone mineralization
Increase protein catabolism Management Sodium bicarbonate treatment

39 Volume Overload Edema Shortness of breath, DOE, PND, Orthopnea CHF HTN

40 Volume Overload Management: Fluid restriction Diuretics
DC medications that may contribute to sodium and water retention

41 Hyperkalemia Increases in serum potassium level and generally more prevalent in later stages of CKD Assessment: Elevated serum potassium level EKG changes Muscle weakness

42 Hyperkalemia Management
Low K + Diet Careful use of medications (ACEI & ARBS and aldosterone inhibitors) that may contribute to hyperkalemia Sodium polystyrene Dialysis if indicated

43 Stage 4 GFR 29 - 15 ml/min Treat complications
Prepare for renal replacement therapy

44 Management of CKD Taking care of the BEANS B = Blood pressure E = EPO
A = Access for long term dialysis N = Nutritional care S = Specialist referral

45 B = Blood Pressure Control
ACEI or ARB < 130/80 HTN exacerbates the vascular complications of diabetes DM plus HTN have 5-6 fold higher risk of developing CKD 6 than HTN alone

46 E = Erythropoietin Higher HCT improves LVH and CHF
When Hgb < 10 or HCT < 30 Check Fe, TIBC, Ferritin Check stools for occult blood Improved Hgb leads to improved energy levels and ability to work

47 A = Access Ideally-early creation of simple AV fistula with 3-6 months to mature Avoid subclavian catheters secondary to subclavian stenosis

48 A = Access cont.. Create AV fistula when serum creatinine is greater than 4 or GFR < 20 ml/min Synthetic AV grafts inserted can be uses 2-4 weeks after placement CAPD catheters inserted 3-4 weeks before use

49 N = Nutrition Malnutrition in CKD 5 extremely common
Albumin is marker of nutrition 2 year mortality > 3.0 g/dl = 20-30% 2 year mortality < 3.0 g/dl = 30-40%

50 N = Nutrition cont.. Uremic anorexia often causes spontaneous protein restriction Folate Avoid vitamins A,C, titrate D3 carefully

51 N = Nutrition cont.. Phosphorus should be kept at level between 3.5 and 5.0 Use calcium acetate or calcium carbonate Renagel, Lanthanum Sensipar Ideally dietary PO4 less than or equal to 1 Gm/day

52 S = Specialist Referral
Acute GN, nephrosis-see Nephrologist ASAP See Nephrology GFR < 30 Serum creatinine 3.0 or more

53 S = Specialist Referral cont..
Gateway to Early dialysis access Renal Dietician Renal Social Worker RN Educators Continuation and nurture of primary care-patient relationship after dialysis begins


Download ppt "Chronic Kidney Disease CKD"

Similar presentations


Ads by Google